Literature DB >> 3156595

TCDD (2,3,7,8-tetrachlorodibenzo-p-dioxin) causes increases in protein kinases particularly protein kinase C in the hepatic plasma membrane of the rat and the guinea pig.

D W Bombick, B V Madhukar, D W Brewster, F Matsumura.   

Abstract

To study the cause of TCDD-evoked changes in the functions of plasma membrane constituents TCDD's effects on protein kinase activities in the liver of rats and guinea pigs were investigated. TCDD was found to cause a sharp increase in both c-AMP independent and dependent protein kinase activities in plasma membrane preparations from rat liver within 48 hours from the time of administration. Such effects reached maxima around day 20, and were quite noticeable even 40 days after a single administration of TCDD. As a result of SDS-polyacrylamide gel-electrophoresis (SDS-PAGE) analysis several substrate proteins for these increased protein kinases were observed. Among them are 170 K - 150 K bands, representing EGF receptor protein. TCDD was found to particularly stimulate protein kinase C which is known to influence many enzyme and receptor functions through protein phosphorylation. The possible significance of such an action of TCDD is discussed.

Entities:  

Mesh:

Substances:

Year:  1985        PMID: 3156595     DOI: 10.1016/s0006-291x(85)80158-3

Source DB:  PubMed          Journal:  Biochem Biophys Res Commun        ISSN: 0006-291X            Impact factor:   3.575


  12 in total

1.  Heart as a target organ in 2,3,7,8-tetrachlorodibenzo-p-dioxin toxicity: decreased beta-adrenergic responsiveness and evidence of increased intracellular calcium.

Authors:  L Canga; R Levi; A B Rifkind
Journal:  Proc Natl Acad Sci U S A       Date:  1988-02       Impact factor: 11.205

Review 2.  The Ah receptor and the mechanism of dioxin toxicity.

Authors:  J P Landers; N J Bunce
Journal:  Biochem J       Date:  1991-06-01       Impact factor: 3.857

3.  Selective Ah receptor ligands mediate enhanced SREBP1 proteolysis to restrict lipogenesis in sebocytes.

Authors:  Gulsum E Muku; Nicholas Blazanin; Fangcong Dong; Philip B Smith; Diane Thiboutot; Krishne Gowda; Shantu Amin; Iain A Murray; Gary H Perdew
Journal:  Toxicol Sci       Date:  2019-06-21       Impact factor: 4.849

4.  Effect of 2,3,7,8-tetrachlorodibenzo-p-dioxin on growth factor expression in the human breast cancer cell line MCF-7.

Authors:  C Vogel; J Abel
Journal:  Arch Toxicol       Date:  1995       Impact factor: 5.153

5.  Growth stimulation of primary rat hepatocytes by 2,3,7,8-tetrachlorodibenzo-p-dioxin.

Authors:  D Wölfle; E Becker; C Schmutte
Journal:  Cell Biol Toxicol       Date:  1993 Jan-Mar       Impact factor: 6.691

6.  Stimulation of NADPH-dependent reactive oxygen species formation and DNA damage by 2,3,7,8-tetrachlorodibenzo-p-dioxin in rat peritoneal lavage cells.

Authors:  N Z Alsharif; W J Schlueter; S J Stohs
Journal:  Arch Environ Contam Toxicol       Date:  1994-04       Impact factor: 2.804

7.  Ah receptor antagonism represses head and neck tumor cell aggressive phenotype.

Authors:  Brett C DiNatale; Kayla Smith; Kaarthik John; Gowdahalli Krishnegowda; Shantu G Amin; Gary H Perdew
Journal:  Mol Cancer Res       Date:  2012-08-21       Impact factor: 5.852

8.  The possible role of phospholipase A2 in hepatic microsomal lipid peroxidation induced by 2,3,7,8-tetrachlorodibenzo-p-dioxin in rats.

Authors:  Z A al-Bayati; S J Stohs
Journal:  Arch Environ Contam Toxicol       Date:  1991-04       Impact factor: 2.804

9.  Dioxin-dependent activation of murine Cyp1a-1 gene transcription requires protein kinase C-dependent phosphorylation.

Authors:  F Carrier; R A Owens; D W Nebert; A Puga
Journal:  Mol Cell Biol       Date:  1992-04       Impact factor: 4.272

10.  2,3,7,8-Tetrachlorodibenzo-p-dioxin causes increases in expression of c-erb-A and levels of protein-tyrosine kinases in selected tissues of responsive mouse strains.

Authors:  D W Bombick; J Jankun; K Tullis; F Matsumura
Journal:  Proc Natl Acad Sci U S A       Date:  1988-06       Impact factor: 11.205

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.